SIRPαFc treatment targets human acute myeloid leukemia stem cells

par Galkin, Oleksandr, McLeod, Jessica, Kennedy, James A., Jin, Liqing, Mbong, Nathan, Wong, Mark, Uger, Robert A., Minden, Mark D., Danska, Jayne S., Wang, Jean C.Y.
Publié dans Haematologica (2020)

AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody–Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML

par Pereira, Daniel S., Guevara, Claudia I., Jin, Liqing, Mbong, Nathan, Verlinsky, Alla, Hsu, Ssucheng J., Aviña, Hector, Karki, Sher, Abad, Joseph D., Yang, Peng, Moon, Sung-Ju, Malik, Faisal, Choi, Michael Y., An, Zili, Morrison, Kendall, Challita-Eid, Pia M., Doñate, Fernando, Joseph, Ingrid B.J., Kipps, Thomas J., Dick, John E., Stover, David R.
Publié dans Mol Cancer Ther (2015)

CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells

par Surka, Christine, Jin, Liqing, Mbong, Nathan, Lu, Chin-Chun, Jang, In Sock, Rychak, Emily, Mendy, Derek, Clayton, Thomas, Tindall, Elizabeth, Hsu, Christy, Fontanillo, Celia, Tran, Eileen, Contreras, Adrian, Ng, Stanley W. K., Matyskiela, Mary, Wang, Kai, Chamberlain, Philip, Cathers, Brian, Carmichael, James, Hansen, Joshua, Wang, Jean C. Y., Minden, Mark D., Fan, Jinhong, Pierce, Daniel W., Pourdehnad, Michael, Rolfe, Mark, Lopez-Girona, Antonia, Dick, John E., Lu, Gang
Publié dans Blood (2021)